U.S. market Closed. Opens in 17 hours 12 minutes

IMVT | Immunovant, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue231.00K1.32M1.23M998.00K21.00KN/AN/A
Gross Profit-231.00K-1.32M-1.23M-998.00K-21.00KN/AN/A
Operating Expenses269.98M208.28M156.03M108.12M66.08M28.58K450.00
Selling, General & Admin57.05M48.02M54.23M39.51M18.15M2.69KN/A
Research & Development212.93M160.26M101.81M68.60M47.93M25.73KN/A
Other Operating Expenses12.50M-253.00K-781.00K328.00K412.00KN/A450.00
Operating Income-270.21M-198.47M-156.16M-107.79M-65.67M-28.43K-450.00
Other Expenses / Income11.44M-12.48M-655.00K328.00K-625.00K-155.00N/A
Before Tax Income-258.77M-210.95M-156.81M-107.79M-66.29M-28.58K-450.00
Income Tax Expenses567.00K9.00K-84.00K-358.00K97.00K19.00N/A
Net Income-259.34M-210.96M-156.73M-107.43M-66.39M-28.60K-450.00
Interest ExpensesN/A12.48M655.00KN/A625.00KN/AN/A
Basic Shares Outstanding138.10M123.08M109.68M87.76M43.20M22.17K12.50M
Diluted Shares Outstanding138.10M123.08M109.68M87.76M43.20M22.17K12.50M
EBITDA-269.98M-198.28M-156.03M-107.72M-65.64M-28.41K-450.00
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-258.77M-198.47M-156.16M-107.79M-65.67M-28.58K-450.00
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙